HOB Biotech Group Corp.,Ltd Share Price
Equities
688656
CNE100004C37
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.78 CNY | +0.61% | +2.65% | -28.71% |
Sales 2022 | 320M 44.25M 3.48B | Sales 2023 | 394M 54.47M 4.28B | Capitalization | 2.19B 303M 23.79B |
---|---|---|---|---|---|
Net income 2022 | 41M 5.66M 445M | Net income 2023 | 47M 6.49M 510M | EV / Sales 2022 | 5.9 x |
Net cash position 2022 | 224M 30.88M 2.43B | Net cash position 2023 | 108M 14.86M 1.17B | EV / Sales 2023 | 5.28 x |
P/E ratio 2022 |
50.8
x | P/E ratio 2023 |
47
x | Employees | 550 |
Yield 2022 |
0.89% | Yield 2023 |
1.15% | Free-Float | 20.83% |
1 day | +0.61% | ||
1 week | +2.65% | ||
1 month | -0.72% | ||
3 months | -5.06% | ||
6 months | -36.93% | ||
Current year | -28.71% |
Managers | Title | Age | Since |
---|---|---|---|
John Li
CEO | Chief Executive Officer | 61 | 31/12/06 |
Shu Yan Han
DFI | Director of Finance/CFO | 44 | 06/07/23 |
Hai Yun Jiao
CHM | Chairman | 46 | 31/03/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Li
CEO | Chief Executive Officer | 61 | 31/12/06 |
Hai Yun Jiao
CHM | Chairman | 46 | 31/03/15 |
Kai Wang
BRD | Director/Board Member | 60 | 30/09/13 |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 24.78 | +0.61% | 231,140 |
30/05/24 | 24.63 | +0.12% | 260,710 |
29/05/24 | 24.6 | +2.76% | 447,069 |
28/05/24 | 23.94 | -0.50% | 349,868 |
27/05/24 | 24.06 | -0.33% | 300,009 |
End-of-day quote Shanghai S.E., May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-28.71% | 215M | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- 688656 Stock